Showing results (141-150 of 313) with videos related to

Sort By:
Pageof 32
Therapeutic Advances in Hematology|April 2, 2014
Outcomes of patients with myelodysplatic syndrome and chronic myelomonocytic leukemia post clofarabine failureHady Ghanem, Guillermo Garcia-Manero, Stefan Faderl, et al.
Leukemia Research|July 6, 2004
Extramedullary relapse in a patient with acute promyelocytic leukemia: successful treatment with arsenic trioxide, all-trans retinoic acid and gemtuzumab ozogamicin therapiesApostolia-Maria Tsimberidou, Elihu Estey, Gary J Whitman, et al.
Blood|May 20, 2006
Survival benefit with imatinib mesylate versus interferon-alpha-based regimens in newly diagnosed chronic-phase chronic myelogenous leukemiaHagop M Kantarjian, Moshe Talpaz, Susan O'Brien, et al.
Cancer|May 10, 2012
Clinical and proteomic characterization of acute myeloid leukemia with mutated RASTapan M Kadia, Hagop Kantarjian, Steven Kornblau, et al.
Cancer|July 14, 2011
A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with higher-risk myelodysplastic syndromeStefan Faderl, Guillermo Garcia-Manero, Elias Jabbour, et al.
Cancer|December 7, 2005
Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemiaDeborah A Thomas, Andreas H Sarris, Jorge Cortes, et al.
Cancer|February 25, 2003
A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndromeJorge Cortes, Hagop Kantarjian, Maher Albitar, et al.
Cancer|March 11, 2003
Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromesApostolia Tsimberidou, Elihu Estey, Jorge Cortes, et al.
Blood|June 21, 2008
A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndromeStefan Faderl, Farhad Ravandi, Xuelin Huang, et al.
Cancer|August 20, 2009
The heterogeneous prognosis of patients with myelodysplastic syndrome and chromosome 5 abnormalities: how does it relate to the original lenalidomide experience in MDS?Hagop Kantarjian, Susan O'Brien, Farhad Ravandi, et al.
Pageof 32